Cassava Sciences Files 8-K on Financials
Ticker: FLNA · Form: 8-K · Filed: Aug 14, 2025 · CIK: 1069530
| Field | Detail |
|---|---|
| Company | Cassava Sciences INC (FLNA) |
| Form Type | 8-K |
| Filed Date | Aug 14, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Cassava Sciences dropped an 8-K on financials, check it out.
AI Summary
Cassava Sciences, Inc. filed an 8-K on August 14, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The company, previously known as Pain Therapeutics Inc., is incorporated in Delaware and headquartered in Austin, Texas.
Why It Matters
This filing provides an update on Cassava Sciences' financial performance and condition, which is crucial for investors to assess the company's ongoing operations and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Cassava Sciences, Inc. (company) — Registrant
- Pain Therapeutics Inc. (company) — Former company name
- August 14, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Austin, Texas (location) — Principal Executive Offices
- 512-501-2444 (phone_number) — Registrant's telephone number
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported is August 14, 2025.
What is Cassava Sciences, Inc.'s principal executive office address?
The principal executive offices are located at 6801 N Capital of Texas Highway, Building 1; Suite 300, Austin, Texas 78731.
What was Cassava Sciences, Inc. previously named?
The company was formerly known as Pain Therapeutics Inc.
In which state is Cassava Sciences, Inc. incorporated?
Cassava Sciences, Inc. is incorporated in Delaware.
Filing Stats: 502 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2025-08-14 07:45:28
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value SAVA NASDAQ Capital Market
Filing Documents
- f8k_081425.htm (8-K) — 15KB
- exh_991.htm (EX-99.1) — 65KB
- 0001171843-25-005406.txt ( ) — 284KB
- gnw-20250101.xsd (EX-101.SCH) — 3KB
- gnw-20250101_def.xml (EX-101.DEF) — 25KB
- gnw-20250101_lab.xml (EX-101.LAB) — 35KB
- gnw-20250101_pre.xml (EX-101.PRE) — 24KB
- f8k_081425_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On August 14, 2025, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information provided in this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit Number Description 99.1 Press Release dated August 14, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cassava Sciences, Inc. a Delaware corporation Date: August 14, 2025 By: /s/ Eric J. Schoen Eric J. Schoen Chief Financial Officer